Prince Joshua S.

Prince Joshua S. is listed in filings as Chief Operating Officer at VistaGen Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 9, 2026, including 8 public disclosures. Recent filings connect the profile to VistaGen Therapeutics, Inc. (VTGN). The current snapshot covers public activity from Jun 26, 2024 to Apr 9, 2026. Reported amounts are shown as $30.1K to $2.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.